Picton Mahoney Asset Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,605
Closed -$2.18M 405
2020
Q4
$2.18M Sell
12,605
-1,221
-9% -$198K 0.1% 219
2020
Q3
$1.93M Sell
13,826
-644
-4% -$86K 0.11% 206
2020
Q2
$1.73M Sell
14,470
-230
-2% -$27.3K 0.1% 184
2020
Q1
$1.47M Buy
14,700
+100
+0.7% +$12K 0.08% 187
2019
Q4
$1.72M Buy
+14,600
New +$1.45M 0.12% 127
2017
Q4
Sell
-8,400
Closed -$764K 219
2017
Q3
$764K Sell
8,400
-100
-1% -$8.56K 0.06% 155
2017
Q2
$633K Hold
8,500
0.05% 162
2017
Q1
$796K Buy
8,500
+100
+1% +$9.06K 0.05% 150
2016
Q4
$611K Buy
+8,400
New +$719K 0.05% 151

Other funds holding NVRO

Picton Mahoney Asset Management's NVRO Position: Q1 2021 in Review

Picton Mahoney Asset Management sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 12,605 shares — an estimated $2.18M sold.

Picton Mahoney Asset Management first reported a position in NVRO in Q4 2016 and held it in 9 quarters. The position peaked at $2.18M in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

  • Picton Mahoney Asset Management reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 12,605 NEVRO CORP. shares in Q1 2021, an estimated $2.18M.
  • Picton Mahoney Asset Management first reported a position in NEVRO CORP. in Q4 2016 and held it in 9 quarters.
  • Picton Mahoney Asset Management's NEVRO CORP. position peaked at $2.18M in Q4 2020.
  • 204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2021, filed 4 May 2021.